TheStreet downgraded shares of Cardinal Health (NYSE:CAH) from a c+ rating to a d rating in a research note issued to investors on Thursday, TheStreetRatingsTable reports.
Other equities analysts have also issued research reports about the stock. Deutsche Bank started coverage on shares of Cardinal Health in a research report on Thursday, September 12th. They set a hold rating and a $50.00 target price on the stock. ValuEngine raised shares of Cardinal Health from a strong sell rating to a sell rating in a research report on Wednesday, October 2nd. Argus lowered shares of Cardinal Health from a buy rating to a hold rating in a research report on Tuesday, August 27th. Morgan Stanley dropped their target price on shares of Cardinal Health from $50.00 to $41.00 and set an underweight rating on the stock in a research report on Friday, September 6th. Finally, Guggenheim set a $55.00 target price on shares of Cardinal Health and gave the stock a buy rating in a research report on Thursday, September 12th. Three analysts have rated the stock with a sell rating, seven have assigned a hold rating and one has given a buy rating to the company. The stock presently has an average rating of Hold and an average target price of $53.50.
CAH stock traded up $0.55 on Thursday, reaching $53.75. 3,313,580 shares of the company were exchanged, compared to its average volume of 2,953,817. Cardinal Health has a 12 month low of $41.03 and a 12 month high of $58.31. The stock’s fifty day moving average price is $48.75 and its 200 day moving average price is $46.39. The firm has a market capitalization of $15.06 billion, a PE ratio of 10.18, a PEG ratio of 1.72 and a beta of 1.32. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.07 and a quick ratio of 0.54.
Institutional investors and hedge funds have recently bought and sold shares of the business. Price T Rowe Associates Inc. MD boosted its stake in Cardinal Health by 5.5% during the second quarter. Price T Rowe Associates Inc. MD now owns 4,205,388 shares of the company’s stock worth $198,074,000 after buying an additional 217,385 shares in the last quarter. Zeke Capital Advisors LLC boosted its stake in shares of Cardinal Health by 370.7% in the 3rd quarter. Zeke Capital Advisors LLC now owns 24,322 shares of the company’s stock valued at $1,148,000 after purchasing an additional 19,155 shares in the last quarter. ARP Americas LP boosted its stake in shares of Cardinal Health by 197.2% in the 2nd quarter. ARP Americas LP now owns 62,399 shares of the company’s stock valued at $2,939,000 after purchasing an additional 41,400 shares in the last quarter. BBT Capital Management LLC acquired a new stake in shares of Cardinal Health in the 2nd quarter valued at $278,000. Finally, Marshall Wace LLP acquired a new stake in shares of Cardinal Health in the 2nd quarter valued at $6,399,000. Hedge funds and other institutional investors own 90.17% of the company’s stock.
About Cardinal Health
Cardinal Health, Inc operates as an integrated healthcare services and products company in the United States and internationally. It provides medical products and pharmaceuticals, and solutions that enhance supply chain efficiency for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices.
Featured Article: What is Put Option Volume?
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.